VPC
SLDB icon

Vestal Point Capital’s Solid Biosciences SLDB Stock Holding History

Vestal Point Capital’s Portfolio SLDB Stock Details SLDB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$36M Sell
5,000,000
-815,000
-14% -$5.24M 1.01% 35
2025
Q4 		$32.8M Buy
5,815,000
+2,840,000
+95% +$15.4M 1.12% 28
2025
Q3 		$18.4M Buy
2,975,000
+1,470,000
+98% +$8.6M 0.83% 42
2025
Q2 		$7.33M Sell
1,505,000
-248,558
-14% -$879K 0.39% 48
2025
Q1 		$6.49M Sell
1,753,558
-1,096,442
-38% -$4.69M 0.46% 40
2024
Q4 		$11.4M Buy
2,850,000
+50,000
+2% +$275K 0.68% 41
2024
Q3 		$19.5M Buy
2,800,000
+135,000
+5% +$1.09M 1.48% 23
2024
Q2 		$15.1M Buy
2,665,000
+1,630,000
+157% +$14.6M 1.13% 29
2024
Q1 		$13.8M Buy
1,035,000
+1,000,915
+2,937% +$9.37M 1.14% 22
2023
Q4 		$209K Buy
+34,085
New +$109K 0.02% 46

Other funds holding SLDB

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM